Front. Neurosci. Frontiers in Neuroscience Front. Neurosci. 1662-453X Frontiers Media S.A. 10.3389/fnins.2024.1386314 Neuroscience Correction Corrigendum: Preventing sleep disruption with bright light therapy during chemotherapy for breast cancer: a phase II randomized controlled trial Rissling Michelle 1 Liu Lianqi 2 Youngstedt Shawn D. 3 Trofimenko Vera 4 Natarajan Loki 5 6 Neikrug Ariel B. 7 Jeste Neelum 8 Parker Barbara A. 2 6 Ancoli-Israel Sonia 1 6 * 1Department of Psychiatry, University of California, San Diego, San Diego, CA, United States 2Department of Medicine, University of California, San Diego, San Diego, CA, United States 3Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, United States 4St. Joseph Hospital, Orange, CA, United States 5Family Medicine and Public Health, University of California, San Diego, San Diego, CA, United States 6Moores Cancer Center, University of California, San Diego, San Diego, CA, United States 7Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, CA, United States 8Johnson & Johnson, San Diego, CA, United States

Edited and reviewed by: Joy Perrier, Neuropsychologie et Imagerie de la Mémoire Humaine, France

 *Correspondence: Sonia Ancoli-Israel sancoliisrael@health.ucsd.edu 03 10 2024 2024 18 1386314 15 02 2024 01 07 2024 Copyright © 2024 Rissling, Liu, Youngstedt, Trofimenko, Natarajan, Neikrug, Jeste, Parker and Ancoli-Israel. 2024 Rissling, Liu, Youngstedt, Trofimenko, Natarajan, Neikrug, Jeste, Parker and Ancoli-Israel

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Preventing sleep disruption with bright light therapy during chemotherapy for breast cancer: a phase II randomized controlled trial by Rissling, M., Liu, L., Youngstedt, S. D., Trofimenko, V., Natarajan, L., Neikrug, A. B., Jeste, N., Parker, B. A., and Ancoli-Israel, S. (2022). Front. Neurosci. 16:815872. doi: 10.3389/fnins.2022.815872 breast cancer light therapy sleep actigraphy PSQI activity section-at-acceptance Sleep and Circadian Rhythms

In the published article, there was an error in Table 2 as published. The sample size numbers were reversed. The Bright White Light Group sample size numbers in the original table were really the sample sizes for the Dim Red Light group, and visa versa. The correct sample size numbers appear in the corrected table. The corrected Table 2 and its caption appear below.

Mean (SE) PSQI total and component scores by group condition and mixed model analysis.

PSQI Bright white light Dim red light
Baseline N = 22 C1TW N = 17 C1RW N= 18 C4TW N = 16 C4RW N = 15 Baseline N = 16 C1TW N = 14 C1RW N = 13 C4TW N = 14 C4RW N = 14
Global 8.9 (0.9) 9.1 (0.8) 8.6 (1.0) 8.5 (0.9) 6.9 (0.9) 7.9 (0.9) 8.1 (1.1) 7.1 (1.3) 7.9 (0.9) 6.9 (1.1)
Subjective sleep quality 1.3 (0.2) 1.4 (0.2) 1.0 (0.2) 0.9 (0.2) 0.4** (0.1) 1.6 (0.2) 1.4 (0.3) 1.0* (0.3) 1.1 (0.2) 0.9* (0.2)
Sleep latency 1.4 (0.2) 1.4 (0.2) 1.4 (0.2) 0.9 (0.3) 0.8 (0.3) 1.5 (0.3) 1.1 (0.3) 1.2 (0.3) 1.0 (0.3) 1.3 (0.3)
Sleep duration 1.3 (0.2) 0.9 (0.2) 0.9 (0.2 0.9 (0.2) 0.9* (0.2) 0.8 (0.1) 0.8 (0.2) 0.5 (0.2) 0.4 (0.2) 0.5 (0.1)
Habitual sleep efficiency 1.8 (0.3) 1.9 (0.3) 1.3 (0.3) 1.6 (0.3) 1.1 (0.3) 1.3 (0.3) 0.9 (0.3) 0.9 (0.3) 1.2 (0.4) 0.7 (0.3)
Sleep disturbances 1.5 (0.1) 1.4 (0.2) 1.2 (0.1) 1.3 (0.2) 1.1* (0.2) 1.6 (0.1) 1.5 (0.2) 1.4 (0.1) 1.7 (0.2) 1.5 (0.1)
Use of sleeping medication 1.1 (0.3) 1.4 (0.4) 1.7 (0.3) 1.8 (0.4) 1.6 (0.4) 0.7 (0.3) 1.5* (0.4) 1.3 (0.4) 1.4* (0.4) 1.2 (0.4)
Daytime dysfunction 0.6 (0.2) 0.8 (0.2) 0.9 (0.2) 1.1* (0.1) 1.0* (0.2) 0.6 (0.2) 0.9 (0.2) 0.7 (0.2) 1.0 (0.2) 0.8 (0.2)

Compared to Baseline in each group: *p < 0.05, **p < 0.01; there were no significant group by time interaction for both groups at any time point (all p's > 0.1).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.